Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo
The nuclear receptor, NR1C2 or peroxisome proliferator-activated receptor (PPAR)-δ, is ubiquitously expressed and important for placental development, fatty acid metabolism, wound healing, inflammation, and tumour development. PPARδ has been hypothesized to function as both a ligand activated transc...
Saved in:
| Main Authors: | Larry G. Higgins, Wojciech G. Garbacz, Mattias C. U. Gustafsson, Sitheswaran Nainamalai, Peter R. Ashby, C. Roland Wolf, Colin N. A. Palmer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2012/216817 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo.
by: Katrin Hack, et al.
Published: (2012-01-01) -
NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
by: Gerardo G. Mackenzie, et al.
Published: (2008-01-01) -
Regulation of Cell Proliferation and Differentiation by PPARβ/δ
by: Rolf Müller, et al.
Published: (2008-01-01) -
PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
by: Robert I. Glazer
Published: (2016-01-01) -
PPARδ Activity in Cardiovascular Diseases: A Potential Pharmacological Target
by: Angela Tesse, et al.
Published: (2009-01-01)